Psychiatry Research: Neuroimaging
Volume 147, Issue 2 , Pages 163-171 , 30 October 2006

Left temporal perfusion associated with suspiciousness score on the Brief Psychiatric Rating Scale in schizophrenia

  • Tomoya Kohno

      Affiliations

    • Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Japan
    • Corresponding Author InformationCorresponding author. Tel./fax: +81 11 706 7155.
    • ,
  • Tohru Shiga

      Affiliations

    • Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Japan
    • ,
  • Ichiro Kusumi

      Affiliations

    • Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan
    • ,
  • Tetsuaki Matsuyama

      Affiliations

    • Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan
    • ,
  • Hiroyuki Kageyama

      Affiliations

    • Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Japan
    • ,
  • Chietsugu Katoh

      Affiliations

    • Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Japan
    • ,
  • Tsukasa Koyama

      Affiliations

    • Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan
    • ,
  • Nagara Tamaki

      Affiliations

    • Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Japan

Received 29 September 2005 ,Revised 25 January 2006 ,Accepted 29 January 2006.

References 

  1. Alberici A, Gobbo C, Panzacchi A, Nicosia F, Ghidoni R, Benussi L, et al. Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier. Journal of Neurology, Neurosurgery and Psychiatry. 2004;75:1607–1610
  2. American Psychiatric Association . DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: APA; 1994;
  3. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa; 1984;
  4. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles-Ponto LL, et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet. 1997;349:1730–1734
  5. Bense S, Deutschlander A, Stephan T, Bartenstein P, Schwaiger M, Brandt T, et al. Preserved visual–vestibular interaction in patients with bilateral vestibular failure. Neurology. 2004;63:122–128
  6. Berman I, Merson A, Sison C, Allan E, Schaefer C, Loberboym M, et al. Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study. Psychopharmacology Bulletin. 1996;32:95–100
  7. Bertolino A, Blasi G, Caforio G, Latorre V, De Candia M, Rubino V, et al. Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine. Biological Psychiatry. 2004;56:190–197
  8. Catafau AM, Parellada E, Lomen¯a FJ, Bernardo M, Pavia J, Ros D, et al. Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. Journal of Nuclear Medicine. 1994;35:935–941
  9. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Transactions on Nuclear Science. 1978;25:638–643
  10. Chiu NT, Lee BF, Hsiao S, Pai MC. Educational level influences regional cerebral blood flow in patients with Alzheimer's disease. Journal of Nuclear Medicine. 2004;45:1860–1863
  11. Copolov DL, Seal ML, Maruff P, Ulusoy R, Wong MT, Tochon-Danguy HJ, et al. Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Research: Neuroimaging. 2003;122:139–152
  12. Erkwoh R, Sabri O, Steinmeyer EM, Bull U, Sass H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatrica Scandinavica. 1997;96:51–57
  13. Friston KJ. Commentary and opinion: II. Statistical parametric mapping: ontology and current issues. Journal of Cerebral Blood Flow and Metabolism. 1995;15:361–370
  14. Ganguli R, Singh A, Brar J, Carter C, Mintun M. Hydrocortisone induced regional cerebral activity changes in schizophrenia: a PET scan study. Schizophrenia Research. 2002;56:241–247
  15. Grabowski TJ, Damasio H, Eichhorn GR, Tranel D. Effects of gender on blood flow correlates of naming concrete entities. Neuroimage. 2003;20:940–954
  16. Honey GD, Sharma T, Suckling J, Giampietro V, Soni W, Williams SC, et al. The functional neuroanatomy of schizophrenic subsyndromes. Psychological Medicine. 2003;33:1007–1018
  17. Inagaki A, Inada T, Fujii Y. Equivalent Dose of Psychotropics. Tokyo: Seiwa Shoten; 1999;
  18. Inagaki A, Inada T, Fujii Y. Dose equivalence of psychotropic drugs: Part XV. Dose equivalence of novel neuroleptics. Perospirone. Japanese Journal of Clinical Pharmacology. 2001;4:869–870
  19. Jaeger JJ, Lockwood AH, Van Valin RD, Kemmerer DL, Murphy BW, Wack DS. Sex differences in brain regions activated by grammatical and reading tasks. Neuroreport. 1998;9:2803–2807
  20. Jibiki I, Matsuda H, Yamaguchi N, Kurokawa K, Hisada K. Acutely administered haloperidol-induced widespread reduction of regional cerebral blood flow observed from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propyleneamine oxime. Neuropsychobiology. 1990–1991;24:125–128
  21. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry. 1988;45:789–796
  22. Kitamura T, Machizawa S, Maruyama S, Nakagawa Y, Morita M, Sato T. Test–retest reliability of Oxford University version of the Brief Psychiatric Rating Scale (BPRS): a preliminary survey of multicenter collaborative study initiated by the National Institute of Mental Health. Journal of Mental Health. 1985;32:1–15
  23. Kolakowska T. Brief Psychiatric Rating Scale: Glossaries and Rating Instructions. Oxford: Oxford University Press; 1976;
  24. Kosaka H, Omori M, Murata T, Iidaka T, Yamada H, Okada T, et al. Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study. Schizophrenia Research. 2002;57:87–95
  25. Krausz Y, Freedman N, Lester H, Newman JP, Barkai G, Bocher M, et al. Regional cerebral blood flow in patients with mild hypothyroidism. Journal of Nuclear Medicine. 2004;45:1712–1715
  26. Kwon JS, McCarley RW, Hirayasu Y, Anderson JE, Fischer IA, Kikinis R, et al. Left planum temporale volume reduction in schizophrenia. Archives of General Psychiatry. 1999;56:142–148
  27. Lewis SW, Ford RA, Syed GM, Reveley AM, Toone BU. A controlled study of Tc-99m-HMPAO single-photon emission imaging in chronic schizophrenia. Psychological Medicine. 1992;22:27–35
  28. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS. Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry. 1992;160:179–186
  29. Lindauer RJ, Booij J, Habraken JB, Uylings HB, Olff M, Carlier IV, et al. Cerebral blood flow changes during script-driven imagery in police officers with posttraumatic stress disorder. Biological Psychiatry. 2004;56:853–861
  30. Malaspina D, Perera GM, Lignelli A, Marshall RS, Esser PD, Storer S, et al. SPECT imaging of odor identification in schizophrenia. Psychiatry Research: Neuroimaging. 1998;82:53–61
  31. Malaspina D, Storer S, Furman V, Esser P, Printz D, Berman A, et al. SPECT study of visual fixation in schizophrenia and comparison subjects. Biological Psychiatry. 1999;46:89–93
  32. Malaspina D, Harkavy-Friedman J, Corcoran C, Mujica-Parodi L, Printz D, Gorman JM, et al. Resting neural activity distinguishes subgroups of schizophrenia patients. Biological Psychiatry. 2004;56:931–937
  33. Martin JA, Penn DL. Attributional style in schizophrenia: an investigation in outpatients with and without persecutory delusions. Schizophrenia Bulletin. 2002;28:131–141
  34. Min SK, An SK, Jon DI, Lee JD. Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study. Psychiatry Research: Neuroimaging. 1999;90:159–168
  35. Mitelman SA, Shihabuddin L, Brickman AM, Hazlett EA, Buchsbaum MS. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. American Journal of Psychiatry. 2003;160:2154–2168
  36. Molina V, Gispert JD, Reig S, Sanz J, Pascau J, Santos A, et al. Cerebral metabolism and risperidone treatment in schizophrenia. Schizophrenia Research. 2003;60:1–7
  37. Molina V, Gispert JD, Reig S, Pascau J, Martinez R, Sanz J, et al. Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia. International Clinical Psychopharmacology. 2005;20:13–18
  38. Molina V, Gispert JD, Reig S, Sanz J, Pascau J, Santos A, et al. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Psychopharmacology. 2005;178:17–26
  39. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports. 1962;10:799–812
  40. Parellada E, Catafau AM, Bernardo M, Lomena F, Catarineu S, Gonzalez-Monclus E. The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients. Biological Psychiatry. 1998;44:787–790
  41. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. American Journal of Psychiatry. 2002;159:227–237
  42. Puri BK, Lekh SK, Nijran KS, Bagary MS, Richardson AJ. SPECT neuroimaging in schizophrenia with religious delusions. International Journal of Psychophysiology. 2001;40:143–148
  43. Pyne JM, Bean D, Sullivan G. Characteristics of patients with schizophrenia who do not believe they are mentally ill. Journal of Nervous and Mental Disease. 2001;189:146–153
  44. Ragland JD, Coleman AR, Gur RC, Glahn DC, Gur RE. Sex differences in brain–behavior relationships between verbal episodic memory and resting regional cerebral blood flow. Neuropsychologia. 2000;38:451–461
  45. Ragland JD, Gur RC, Raz J, Schroeder L, Kohler CG, Smith RJ, et al. Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. American Journal of Psychiatry. 2001;158:1114–1125
  46. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry. 1999;56:241–247
  47. Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet. 1997;349:1735–1739
  48. Salgado-Pineda P, Junque C, Vendrell P, Baeza I, Bargallo N, Falcon C, et al. Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage. 2004;21:840–847
  49. Shiga T, Kubo N, Takano A, Kobayashi J, Takeda Y, Nakamura F, et al. The effect of scatter correction on 123I-IMP brain perfusion SPET with the triple energy window method in normal subjects using SPM analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2002;29:342–345
  50. Suhara T, Okubo Y, Yasuno F, Sudo Y, Inoue M, Ichimiya T, et al. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Archives of General Psychiatry. 2002;59:25–30
  51. Tauscher J, Kapur S, Verhoeff NP, Hussey DF, Daskalakis ZJ, Tauscher-Wisniewski S, et al. Brain serotonin 5-HT1A receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. Archives of General Psychiatry. 2002;59:514–520
  52. Thermenos HW, Seidman LJ, Breiter H, Goldstein JM, Goodman JM, Poldrack R, et al. Functional activity during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biological Psychiatry. 2004;55:490–500
  53. Verhoeff NP, Soares JC, D'Souza CD, Gil R, Degen K, Abi-Dargham A, et al. [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia. Psychiatry Research: Neuroimaging. 1999;91:163–173
  54. Verhoeff NP, Meyer JH, Kecojevic A, Hussey D, Lewis R, Tauscher J, et al. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia. Psychiatry Research: Neuroimaging. 2000;99:123–135
  55. Vita A, Bressi S, Perani D, Invernizzi G, Giobbio GM, Dieci M, et al. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. American Journal of Psychiatry. 1995;152:876–882
  56. Yasuno F, Suhara T, Okubo Y, Sudo Y, Inoue M, Ichimiya T, et al. Low dopamine D2 receptor binding in subregions of the thalamus in schizophrenia. American Journal of Psychiatry. 2004;161:1016–1022
  57. Yuasa S, Kurachi M, Suzuki M, Kadono Y, Matsui M, Saitoh O, et al. Clinical symptoms and regional cerebral blood flow in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 1995;246:7–12

PII: S0925-4927(06)00022-9

doi: 10.1016/j.pscychresns.2006.01.016

Psychiatry Research: Neuroimaging
Volume 147, Issue 2 , Pages 163-171 , 30 October 2006

Article Tools

* Image Usage & Resolution